Daxxify just tapped a new famous face: Julianne Hough. The dancer, actress and television personality announced her partnership with the FDA-approved neurotoxin on Tuesday, June 23, sharing that she uses the treatment on her “11s,” the vertical lines that can form between the brows.
Like Botox Cosmetic, Dysport, Xeomin and Jeuveau, Daxxify is an injectable neurotoxin that softens expression lines. In Daxxify’s case, it’s specifically FDA-approved to temporarily improve moderate to severe frown lines, also known as glabellar lines, in adults—the same area Hough says she treats.
Daxxify is known for its longevity, with results that often last around six months and, for some patients, up to nine months. As Miami dermatologist Annie Gonzalez, MD, previously told NewBeauty, “Daxxify is the first and only FDA-approved neurotoxin that uses peptide-powered technology. Other products rely on human albumin as a stabilizer, but Daxxify contains no human or animal protein. Instead, it uses a synthetic peptide, which is what allows it to act fast and last longer.”
“I had been intrigued by DAXXIFY long before formally working with the brand, after realizing I needed a product to better align with my extremely busy schedule,” said Hough. “I am constantly on the go and am more often than not on camera dancing, acting and hosting. DAXXIFY fits seamlessly into that lifestyle. More time between visits with my provider means more time doing what I love.”
That longevity has shown up in NewBeauty’s own testing, too. In a comprehensive review of Daxxify, our aesthetic director, Tatiana Bido, wrote that her results lasted nearly five months—longer than her typical neurotoxin treatments—with a gradual, natural-looking fade. As Miami plastic surgeon Jackie Yee, MD, who treated Bido, told her, “I tell all my patients, you don’t know if you’re going to be the person who’s going to last nine months or three months. But you have to try it to know.”
